- About About
-
Medical
Medical
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
-
-
Federal Medical Cannabis Protection Set to Expire at the End of September
As a medical cannabis advocate, you are probably aware that the Rohrabacher-Farr amendment to the Department of Justice’s (DOJ) budget has been helping defendants win in federal court. Beginning with the Marin Alliance for Medical Marijuana ruling last October, to dropping the case against Harborside this May, to the McIntosh victory in the 9th Circuit last month, the amendment has been protecting safe and legal access for patients. The amendment was passed in 2014 and 2015 thanks in part to the support and efforts of medical cannabis activists like you!
Earlier this year, the Senate Appropriations Committee voted overwhelming to include it in next DOJ budget. However, the amendment is set to expire at the end of September and the House has yet to vote on it. If the amendment expires, the federal prosecutions against those obeying their state medical cannabis laws could resume once again.
You can help by sending an email to your representative thanking them for voting yes last year or to encourage those who voted no to take another look at the issue.
Use the take action button below to customize and send the pre-written email.
Share